CAMBRIDGE, Mass. , March 8, 2024 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a clinical-stage global biopharmaceutical company powered by a cutting-edge drug discovery engine and differentiated clinical development pipeline, today ...
WASHINGTON , March 1, 2024 /PRNewswire/ -- To kick off Obesity Care Week 2024, more than 60 advocates with the Obesity Action Coalition (OAC) will gather on Capitol Hill to meet with more than 70 legislators to express the importance of ...
First Patient Expected to be Randomized in the Second Quarter of 2024 CAMBRIDGE, Mass. , Feb. 29, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on ...
Preclinical Studies Show DA-1726 Elicits Superior Weight Loss Compared to Semaglutide (Wegovy™) and Similar Weight Loss Compared to Tirzepatide (Mounjaro™), While Consuming More Food Initiation of Phase 1 Clinical Trial Expected to Occur ...
CAMBRIDGE, Mass. , Dec. 28, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has submitted an ...
TAMPA, Fla. , Nov. 28, 2023 /PRNewswire/ -- The Obesity Action Coalition (OAC) announces the publication of a "Joint Statement in Support of Closing Gaps in the Drug Approval Process and Drug Labeling for People with Obesity." The ...
With over 100 million US adults experiencing obesity, and the condition accounting for $173 billion dollars in extra health costs annually, health tech company Theator set out to examine how bariatric surgeries are stacking up, only to find ...
Mazdutide demonstrates its differentiated advantages as a novel dual agonist of GLP-1 and GCG receptor with superior weight loss efficacy, significant improvement in a series of cardiometabolic indicators (waist circumferenc e, ...
WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Live-stream and In Person Event, October 11 , 2:00 – 4:00 PM, ET National Press Club, Washington DC , or live stream – register here: The State of Obesity: Creating Pathways to a ...
AD-9308 is a potent, and highly selective oral ALDH2 activator ready for IND-enabling development. AD-9308 treatment ameliorates diet-induced obesity and fatty liver, and improves glucose homeostasis in both male Aldh2 wild-type and Aldh2 ...
Doctors state that childhood obesity in India has surged significantly, leading to an unhealthy future for these children . World Obesity Day ( ) is observed every year on March 4 to raise awareness about the condition and its implications.“As a consultant ...
Obesity , smoking , and low levels of physical exercise increase the risk of monoclonal gammopathy of unknown significance (MGUS), a benign blood disorder that frequently precedes multiple myeloma, according to a new study published in Blood ...
New vibrating and ingestible capsule , developed by an Indian-origin engineer at the Massachusetts Institute of Technology (MIT), has the potential to create a feeling of fullness, deceiving the brain into perceiving meal completion, offering a ...
In tackling obesity worldwide , intermittent energy restriction (IER) triggers coordinated shifts in the brain-gut microbiome axis, thereby presenting a promising approach to weight loss for over one billion obese individuals ( ). ...
Eli Lilly's Mounjaro is positioned to outpace Novo Nordisk's Ozempic (semaglutide) and claim the top spot in sales within the obesity and diabetes market....
Subscribe to our Free Newsletters!